相关实验视频

Updated: Sep 17, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

在B细胞淋巴瘤免疫疗法的新视野:从免疫检查点到精确医学

RuiXin Zheng¹, YuXiao Li¹, KaiXin Shi¹

¹Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China.

Neoplasia (New York, N.Y.)

|July 1, 2025

概括

这项研究解读了B细胞淋巴瘤中的免疫检查点作用,突出了PD-1,LAG-3,TIM-3和TIGIT. 了解这些途径可以指导新型免疫疗法,并确定个性化淋巴瘤治疗的生物标志物.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

B细胞淋巴瘤是一种与免疫调节相关的异质恶性瘤.
分子发现的进步提高了理解,但治疗方面仍然存在挑战.
像PD-1,LAG-3,TIM-3和TIGIT这样的免疫检查点对于免疫平衡和癌症进展至关重要.

研究的目的:

系统分析PD-1,LAG-3,TIM-3和TIGIT在B细胞淋巴发育中的免疫检查点轴的分子相互作用.
总结当前的研究,确定现有问题,并探索B细胞淋巴瘤免疫治疗的未来方向.
推进基础科学和临床应用,以改善B细胞淋巴瘤治疗.

主要方法:

系统审查和分析PD-1,LAG-3,TIM-3和TIGIT之间的分子相互作用.
解读淋巴发育过程中共抑制检查点的功能架构.
研究针对性的阻断策略,以恢复抗瘤免疫力.

主要成果:

参与PD-1/PD-L1/PD-L2会损害T淋巴细胞的激活,从而促进瘤的免疫逃避.
了解这些检查点有助于开发精密免疫疗法.
识别生物标志物的潜力,以预测淋巴瘤患者的免疫治疗反应.

结论:

准免疫检查点为B细胞淋巴瘤提供了有希望的化疗策略.
对这些检查点的进一步研究可以导致个性化治疗计划和改善患者的治疗结果.
这项工作为B细胞淋巴瘤免疫治疗的基础研究和临床转化提供了洞察力.

关键词:

在B细胞淋巴瘤.免疫检查点免疫检查点作为一种免疫抑制剂.现场行动组-3 在PD-1中使用PD-1.这是一个紧张的紧张.在TIM-3中,TIM-3是TIM-3.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Special Features of Adaptive Immunity

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...